Results 31 to 40 of about 5,240 (183)
EVALUATION OF HEMATOLOGIC FINDINGS IN MUCOPOLYSACCHARIDOSIS CASES
Introduction: Mucopolysaccharidosis (MPS) are lysosomal storage diseases characterized by chronic, progressive and multiple system involvement due to impaired glycosaminoglycans destruction. There are 7 types of MPS as type I, II, III, IV, VI, VII and IX.
Karaca, Meryem, Cakar, Nafiye Emel
core +1 more source
I-gel assisted fiberoptic intubation in a child with Morquio′s syndrome
Morquio′s syndrome, also known as mucopolysaccharidosis type IV is an autosomal recessive disorder, caused by deficiency of n-acetylgalactosamine-6-sulphate.
Sangeeta Dhanger +3 more
doaj +1 more source
Evaluation of Demographic and Clinical Characteristics of Patients with Mucopolysaccharidosis [PDF]
Aim: Mucopolysaccharidoses (MPSs) are a group of lysosomal storage disorders caused by the deficiency of spesific lysosomal enzymes required to break down glycosaminoglycans.
Engin Köse +7 more
core +1 more source
International audienceBackground Upper airway obstruction is common in children with mucopolysaccharidosis. The acoustic reflection method is a noninvasive technique that can analyse the calibre of the upper airways.
Louis, Bruno +9 more
core +1 more source
Objective: Mucopolysaccharidosis is a rare genetic disease characterized by the intralysosomal deposition of glycosaminoglycans. Cardiovascular impairment is a common feature.
Mirela F.A. Andrade +5 more
doaj +3 more sources
Background: Mucopolysaccharidosis (MPS) is a multisystemic storage disorder of glycosaminoglycan deposits. Infiltration of the dura mater and supporting ligaments caused spinal cord compression and consecutive myelopathy, especially at the cranio ...
Mohamed Zairi +6 more
doaj +1 more source
Treating a teenager with Morquio A syndrome (mucopolysaccharidosis IV A) with Vimizim
The article describes a clinical case of enzyme replacement therapy (ERT) with elosulfase alfa for a teenager with mucopolysaccharidosis type IVA (MPS IVA, Morquio A syndrome). Treatment was started quite late, at the age of 12, against the background of a severe course of Morquio A syndrome. Nevertheless, the child showedan improvement in enduranceand
E. E. Gurinova +3 more
openaire +2 more sources
Morquio B disease (MBD) or Mucopolysaccharidosis type IV B (MPS IV B) is caused by particular GLB1 mutations specifically affecting the affinity of beta-galactosidase to keratan sulphate, resulting in dysostosis multiplex resembling Morquio A (MPS IV A ...
Maria Bleier +4 more
doaj +1 more source
A Case Report of Cardiac Ascites in Morquio Syndrome Complicated by Pulmonary Hypertension
Morquio syndrome, or mucopolysaccharidosis type IV (MPS IV), is a rare lysosomal storage disorder characterized by skeletal dysplasia and dysostosis multiplex.
Gauri Patel, Olakanmi Joseph Deleawe
doaj +1 more source
(1) Background: Mucopolysaccharidoses (MPS) are a heterogeneous group of lysosomal storage disorders caused by the absence of enzymes required for degradation of glycosaminoglycans (GAGs).
Chaitanya Gadepalli +5 more
core +1 more source

